For metastatic cancer is it necessary to treat all tumors/ lesions or does this treatment promote an immune response that will overtake anything outside of the primary tumor. I have a somewhat large breast tumor but also multiple foci in the liver. What would be the treatment approach in this situation?
Yes, for metastatic cancer, we aim to treat all visible tumors/lesions, because this therapy is locally curative, but not systemically circulating like chemotherapy. However, it also induces a strong immune response, which can help clear micrometastases or small untreated lesions — especially when larger tumor masses are eliminated.
⸻
🧬 Here’s how the approach works in a case like yours:
🎯 1. Treat all large or accessible tumors directly
• The large primary breast tumor would typically be treated first (often in 1–2 injections).
• Liver lesions — if visible and accessible by imaging (ultrasound or CT) — are also treated one by one, possibly across 2–3 sessions.
Each injection is highly targeted and takes less than a minute. Most tumors require 1–4 injections total.
🌊 2. Immune activation is a real, secondary benefit
• When the ClO₂ destroys tumor tissue, it causes:
• Release of tumor antigens
• Inflammatory signaling
• Recruitment of innate and adaptive immune cells
This can trigger a systemic immune response, sometimes called an “abscopal-like effect,” which may:
• Help suppress or eliminate tiny micrometastases
• Contribute to long-term surveillance
However, this effect is not guaranteed, so we do not rely on it alone to control widespread disease.
🧩 3. Prioritization strategy
If a patient has multiple tumors and limited capacity for injections in one session, we usually prioritize:
1. Tumors causing the most symptoms
2. Tumors easiest to access
3. Largest tumors (to reduce total tumor burden quickly)
⸻
💡 In Your Case:
With a large breast tumor + multiple liver foci, our protocol would likely be:
• Session 1: Inject the breast tumor (partial volume) + 1–2 accessible liver foci
• Session 2–3 (within 2–3 weeks): Follow-up injections to complete treatment of all visible lesions
• Imaging after each round to confirm necrosis and adjust dosing
⸻
✅ Summary:
For metastatic cases, we do aim to treat all tumors, because this therapy works locally, not systemically, but it can enhance the immune system to help with residual disease. The goal is to leave no viable tumors behind — and in many cases, we achieve complete tumor clearance with zero side effects.
We're in! Traveling to Germany on the 15th, have appointment with Dr Renz on the 17th. Thank you, Xuewu Lui.
Wishing you a smooth journey and a successful treatment in Germany — please keep me updated.
How can a Non Patient Support this LEGALIZATION of this LIFE SAVING TREATMENT?
Any American who can influence state legislation may participate.
For metastatic cancer is it necessary to treat all tumors/ lesions or does this treatment promote an immune response that will overtake anything outside of the primary tumor. I have a somewhat large breast tumor but also multiple foci in the liver. What would be the treatment approach in this situation?
Yes, for metastatic cancer, we aim to treat all visible tumors/lesions, because this therapy is locally curative, but not systemically circulating like chemotherapy. However, it also induces a strong immune response, which can help clear micrometastases or small untreated lesions — especially when larger tumor masses are eliminated.
⸻
🧬 Here’s how the approach works in a case like yours:
🎯 1. Treat all large or accessible tumors directly
• The large primary breast tumor would typically be treated first (often in 1–2 injections).
• Liver lesions — if visible and accessible by imaging (ultrasound or CT) — are also treated one by one, possibly across 2–3 sessions.
Each injection is highly targeted and takes less than a minute. Most tumors require 1–4 injections total.
🌊 2. Immune activation is a real, secondary benefit
• When the ClO₂ destroys tumor tissue, it causes:
• Release of tumor antigens
• Inflammatory signaling
• Recruitment of innate and adaptive immune cells
This can trigger a systemic immune response, sometimes called an “abscopal-like effect,” which may:
• Help suppress or eliminate tiny micrometastases
• Contribute to long-term surveillance
However, this effect is not guaranteed, so we do not rely on it alone to control widespread disease.
🧩 3. Prioritization strategy
If a patient has multiple tumors and limited capacity for injections in one session, we usually prioritize:
1. Tumors causing the most symptoms
2. Tumors easiest to access
3. Largest tumors (to reduce total tumor burden quickly)
⸻
💡 In Your Case:
With a large breast tumor + multiple liver foci, our protocol would likely be:
• Session 1: Inject the breast tumor (partial volume) + 1–2 accessible liver foci
• Session 2–3 (within 2–3 weeks): Follow-up injections to complete treatment of all visible lesions
• Imaging after each round to confirm necrosis and adjust dosing
⸻
✅ Summary:
For metastatic cases, we do aim to treat all tumors, because this therapy works locally, not systemically, but it can enhance the immune system to help with residual disease. The goal is to leave no viable tumors behind — and in many cases, we achieve complete tumor clearance with zero side effects.
I would be interested in the case report, etc. Thank you very much!
Please look for it in my post.
Does this work for prostate cancer and melanoma?
Yes, this therapy is effective for any solid tumor, as long as injection is possible.
Thank you for the response. I would appreciate you sharing that.
And non-tumor cancer like leukemia?
Intratumoral injection of chlorine dioxide, as the name suggests, cannot treat leukemia or other blood cancers.